Menu

Proposed “Japanese NIH” Draws Fire

Scientific societies in Japan contend that a plan for an NIH-like agency to oversee the country’s science ministries will squash basic research.

Jun 25, 2013
Chris Palmer

Skyline of Tokyo’s Shinjuku commercial district. WIKIMEIDA, MORIO

Japanese scientists have expressed serious concerns about Prime Minister Shinzo Abe’s proposal to create a Japanese version of the National Institutes of Health that would coordinate research efforts across several ministries. Abe’s Growth Strategy—a plan for kick starting the country’s economic growth—includes an emphasis on expanding “the commercialization of innovative medical technologies.” The plan also calls for revising regulations to speed the approval of new drugs and medical devices, as well as changes to patent law and tax incentives to spur research commercialization.

A day before the draft plan was released last week, the heads of more than 50 life-science academic societies released a statement supporting the creation of an NIH-like funding agency to support biomedical research. However, the society chiefs also expressed concerns about Abe’s proposal. Their statement (in Japanese here) called for three provisions to the plan: the preservation of a bottom-up approach of promoting basic research; support for developing the next generation of researchers; and sufficient funding to foster true innovation.

At a press conference last week, Akira Amari, minister for economic revitalization, addressed concerns raised by the scientific community. “I would like to stress that we have no intention to try to tie down the people who are involved in very fundamental research,” he said.

Amari also said he has been approached by scientists who tell him that their work “is beginning to show some signs of eventually having some kind of possible commercial application,” but that they are not quite sure what steps to take to move in that direction. “We need to try to help these people,” he said, citing the possibility of collaborations between scientists in industry and academia. “It is very important to have someone in [a research] group who can look at the industrialization or commercialization aspects and provide some direction to the research,” he explained.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Best Practices: Calculating Cell Confluency
Best Practices: Calculating Cell Confluency
In this white paper, learn how to use a cell imager system to directly and accurately capture and calculate cell confluency!
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin's AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the lab. 
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
BCG Digital Ventures and Sartorius Help Launch the World's First Voice-powered Digital Assistant for Scientists
LabTwin GmbH, an independent company backed by Boston Consulting Group Digital Ventures (BCG Digital Ventures) and leading biopharma supplier, Sartorius, today announced the launch of the world's first voice and AI-powered digital lab assistant.
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
Understanding Transcriptomic or Proteomic Datasets to Reveal Biological Mechanisms
When analyzing large transcriptomics or proteomics datasets, we want to understand whether the phenomenon is unusual or commonplace and whether there are informative similarities to other areas of biology. To learn more about how Ingenuity Pathway Analysis (IPA®) and Analysis Match can help, download this white paper from QIAGEN!